NMRDNemaura Medical, Inc.

About Nemaura Medical, Inc. (NMRD)

Nemaura Medical, Inc. (NMRD) is a Medical Devices company headquartered in Manhattan, NY, United States whose shares trade over-the-counter on the Expert Market tier.

Nemaura Medical Inc. (OTCQB:NMRD) is a medical technology company developing sugarBEAT as a non-invasive, affordable and flexible glucose monitoring system for adjunctive use by diabetics. SugarBEAT consists of a disposable skin-patch connected to a rechargeable transmitter, with an app displaying glucose readings.

NMRD key facts

Ticker symbol

NMRD

Market tier

Expert Market

Sector

Healthcare

Industry

Medical Devices

Headquarters

Manhattan, NY, United States

Country of incorporation

US

Year of incorporation

2013

Estimated market cap

$8.1K (as of Apr 16, 2025)

Shares outstanding

40,351,702

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

3/31

Latest filing

8K Report (May 1, 2024)

Nemaura Medical, Inc. leadership

• Dewan F H Chowdhury — CEO
• Iain Anderson — CFO
• Karrar Khan — Director, Prod. Dev.
• David Scott — Director, Comm.
• Richard Toon — Business Development

Explore more: Medical Devices stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with N